COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

Journal: Nature

Published: 2021-04-29

DOI: 10.1038/s41586-021-03570-8

Affiliations: 63

Authors: 109

Go to article
Institutions Share
Broad Institute of MIT and Harvard, United States of America (USA) 0.40
Harvard University, United States of America (USA) 0.11
NanoString Technologies, Inc., United States of America (USA) 0.10
Massachusetts General Hospital (MGH), United States of America (USA) 0.10
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA) 0.08
Brigham and Women's Hospital (BWH), United States of America (USA) 0.06
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA) 0.06
Institute for Molecular Medicine Finland (FIMM), Finland 0.01
Massachusetts Institute of Technology (MIT), United States of America (USA) 0.01
Hansjorg Wyss Institute for Biologically Inspired Engineering, United States of America (USA) 0.01
University of Southern California (USC), United States of America (USA) 0.01
Duke University, United States of America (USA) 0.01
Boston University (BU), United States of America (USA) 0.01
Harvard-MIT Health Sciences and Technology (HST), United States of America (USA) 0.01
Harvard Stem Cell Institute (HSCI), United States of America (USA) 0.01
Stanford University, United States of America (USA) 0
Boston Children's Hospital (BCH), United States of America (USA) 0
Ragon Institute of MGH, MIT and Harvard, United States of America (USA) 0
Massachusetts Consortium on Pathogen Readiness (MASSCPR), United States of America (USA) 0
Howard Hughes Medical Institute (HHMI), United States of America (USA) 0

Return